IL18 and Alzheimer disease: However, other studies have observed that some inflammatory molecules, such as IL‐12, IL‐16, and IL‐18 in patients with severe AD are downregulated,24 which indicates that these inflammatory indicators have disease‐stage dependence and play dual effects, and may be related to the decreased immune response in later patients.